Trials / Completed
CompletedNCT03729570
Electronic Pre-exposure Prophylaxis (PrEP) Initiation and Maintenance Home Care System
Testing an Electronic Pre-exposure Prophylaxis (PrEP) Initiation and Maintenance Home Care System to Promote PrEP Among Adolescent Men Who Have Sex With Men (MSM) in Rural and Small Town Areas
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 217 (actual)
- Sponsor
- Emory University · Academic / Other
- Sex
- Male
- Age
- 18 Years – 29 Years
- Healthy volunteers
- Accepted
Summary
The premise for the study is that a tailored approach for rural young men who have sex with men (YMSM), addressing known barriers of transportation, access to providers, and privacy, is most likely to yield high levels of Pre-exposure Prophylaxis (PrEP) initiation and persistence in care.
Detailed description
The premise for the study is that a tailored approach for YMSM from rural and small town areas, addressing known barriers of transportation, access to providers, and privacy, is most likely to yield high levels of PrEP initiation and persistence in care. The study sites are Alabama, Georgia, North Carolina, and Mississippi. Using a smartphone application (app), participants assigned to the intervention will receive and maintain a PrEP prescription without needing to leave their home (excepting pharmacy pick-up in some cases) - achieved through app-based surveys/screenings, telemedicine consultations, and home specimen self-collection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | ePrEP | Participants will have a baseline teleconsultation with a site study clinician who will be responsible for prescribing PrEP as indicated. They will be offered a 1-month check-in and telemedicine consultations at 3, 6, 9 and 12 months. Participants will complete home specimen collection for laboratory tests for each consultation. The virtual study visit consists of surveys, specimen collection, and a telemedicine consultation. |
Timeline
- Start date
- 2019-05-28
- Primary completion
- 2022-05-31
- Completion
- 2022-05-31
- First posted
- 2018-11-02
- Last updated
- 2024-10-18
- Results posted
- 2024-06-27
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03729570. Inclusion in this directory is not an endorsement.